News

News

Endovastec™ Minos® Stent Graft System Completes First Clinical Implantation in Czech Republic -

The first implantation of the Minos® Abdominal Aortic Stent-Graft and ...

Endovastec™ Receives ISO 50001 Energy Management System Certificate -

Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™...

Subject Enrollment Completed for the MicroPort® NeuroTech Tubridge® Vascular Reconstruction Device IMPACT Study -

The last procedure of the IMPACT Study, a propsective, multicenter pos...

MicroPort® Attends at SOLACI-CACI 2021 with CardioFlow Medtech™ and Endovastec™ -

From the 2nd to 6th of August, 2021, MicroPort® Scientific Corporation...

MicroPort® Wewin Receives CE Mark for its 2019-nCoV PCR Test Kit -

MicroPort® Wewin Diagnostics Co., Ltd (MicroPort® Wewin) recently rece...

MicroPort® Lifesciences Showcases Two Products at the 10th CSE Academic Conference on Diabetes and Gonadal Disorders -

Shanghai MicroPort Lifesciences Co. (MicroPort® Lifesciences) recently...

First Implantation of Castor® Branched Stent-Graft System by MicroPort Endovastec™ Completed in Brazil -

The first implantation of the Castor® Aortic Branched Stent-Graft and ...

CardioFlow Medtech Makes Follow-on Investment in Transcatheter Valve Start-up Valcare -

MicroPort® CardioFlow Medtech Corporation (CardioFlow Medtech) has rec...

MicroPort® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment -

MicroPort Scientific Corporation (“MicroPort®”) announced that MicroPo...

Endovastec™ Attends the Third CMDA-CACVS Annual Academic Congress -

Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec...

MicroPort® EP Represented in the 19th International Forum on Atrial Fibrillation -

Shanghai MicroPort EP MedTech Co., Ltd. (MicroPort® EP) was recently r...

MicroPort® NeuroTech Presents Two New Products at the 7th CSA Annual Academic Conference -

Shanghai MicroPort® NeuroTech Co., Ltd. (MicroPort® NeuroTech) recentl...

MicroPort® Shared the Use of Firehawk® and Firefighter™ in Complex Lesions at the 16th Ice City Conference of Cardiology (ICC2021) -

Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) recently par...

MSC Completed the 1st Rega Series Pacemaker Implantation in Chifeng, China -

The first implantation of Rega series pacemakers developed by MicroPor...

Subject Enrolment Completed for MicroPort® EP Cardiac Cryoablation System Trial -

The IceMagic® Cardiac Cryoablation System (the IceMagic® system), deve...

MicroPort® Orthopedics Receives “15A” ODEP Rating for its Advance® Medial-Pivot Knee System -

MicroPort® Orthopedics received a ‘15A’ rating from the Orthopedic Dat...